In Phase A, individuals will get various doses and schedules of oral ABBV-744 pill to determine safe dosing regimen. Further participants might be enrolled with the discovered monotherapy dosign program. In Section B, contributors will receive oral ruxolitinib and ABBV-744 is going to be specified as "include-on" therapy. In Section https://cashvitfp.vidublog.com/31268856/a-simple-key-for-abbv-744-brd4-inhibition-in-cancer-cell-lines-unveiled